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Abstract  
This project identified a novel family of six 66-68 residue peptides from the venom of two 
Australian funnel-web spiders, Hadronyche sp. 20 and H. infensa: Orchid Beach (Hexathelidae: 
Atracinae), that appear to undergo N- and/or C-terminal post-translational modifications and conform to 
an ancestral protein fold. These peptides all show significant amino acid sequence homology to 
atracotoxin-Hvf17 (ACTX-Hvf17), a non-toxic peptide isolated from the venom of H. versuta, and a 
variety of AVIT family proteins including mamba intestinal toxin 1 (MIT1) and its mammalian and 
piscine orthologs prokineticin 1 (PK1) and prokineticin 2 (PK2). These AVIT family proteins target 
prokineticin receptors involved in the sensitization of nociceptors and gastrointestinal smooth muscle 
activation. Given their sequence homology to MIT1, we have named these spider venom peptides the 
MIT-like atracotoxin (ACTX) family. Using isolated rat stomach fundus or guinea-pig ileum organ bath 
preparations we have shown that the prototypical ACTX-Hvf17, at concentrations up to 1 GM, did not 
stimulate smooth muscle contractility, nor did it inhibit contractions induced by human PK1 (hPK1). 
The peptide also lacked activity on other isolated smooth muscle preparations including rat aorta. 
Furthermore, a FLIPR Ca2+ flux assay using HEK293 cells expressing prokineticin receptors showed 
that ACTX-Hvf17 fails to activate or block hPK1 or hPK2 receptors. Therefore, while the MIT-like 
ACTX family appears to adopt the ancestral disulfide-directed -hairpin protein fold of MIT1, a motif 
believed to be shared by other AVIT family peptides, variations in the amino acid sequence and surface 
charge result in a loss of activity on prokineticin receptors. 
 
1. Introduction 
Recently a novel non-toxic peptide was isolated from the venom of one of the world’s most lethal 
group of arachnids, the Australian funnel-web spiders (Araneae: Hexathelidae: Atracinae) [42]. This 
68-residue protein, ACTX-Hvf17, was isolated from the venom of the Blue Mountains funnel-web 
spider H. versuta. Interestingly, it does not function like classical funnel-web spider atracotoxins to 
modulate mammalian or insect voltage-gated ion channel function (for reviews see [35, 43]) since it 
lacks insecticidal activity and fails to affect vas deferens smooth muscle or skeletal muscle contractility. 
Despite some sequence homology with a variety of colipases it also lacks colipase activity. Accordingly 
we have been interested in identifying the target of ACTX-Hvf17. 
We have recently determined that ACTX-Hvf17 shows significant sequence homology with a 
variety of novel peptides from fish, frog, snake and several mammalian species belonging to the AVIT 
family [19] as shown in Fig. 3. This includes MIT1 from the venom of the black mamba snake 
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Dendroaspis p. polylepis [2, 39], Bv8 (Bombina variegata 8 kDa protein; [32]) and its orthologs Bm8a-f 
(B. maxima 8 kDa protein; [4, 21]) from the skin secretions of toads from Bombina spp., and the recently 
identified prokineticin 1 (PK1; also known as endocrine-gland vascular endothelial growth factor or EG-
VEGF) and prokineticin 2 (PK2) peptides [27]. These are all 77-94 residue peptides, containing 10 
cysteines with conserved spacing, whose N-terminal four residues, ‘AVIT’, are all identical (Fig. 3). All 
these peptides, including ACTX-Hvf17, display some limited sequence homology with a variety of 
colipases but lack colipase activity, are highly resistant to classical specific proteolytic enzymes, and 
have no overt toxic effects in vertebrates or insects [19, 42]. ACTX-Hvf17 shares 32% sequence identity 
with Bv8, including the 10 conserved cysteine residues, and is 44% homologous if conservative 
substitutions are included (Fig. 3). The 3D fold of ACTX-Hvf17 remains undetermined as it is 
intractable to NMR analysis due to aggregation under a wide variety of conditions. Nevertheless, it is 
believed that ACTX-Hvf17 adopts the MIT1/colipase fold [42]. Recently two non-AVIT family peptides 
PRTx16C0 and PRTx16C1 with the highest reported homology to ACTX-Hvf17 have also been isolated 
from the venom of the Brazilian armed spider Phoneutria reidyi (SWISS-PROT data bank accession 
numbers P83893 and P83997) (Fig. 3). Unfortunately, like ACTX-Hvf17, no target has yet been 
identified for these non-toxic arachnid peptides. This is not unique with only a few conotoxins within the 
venom of marine cone snails (Conus spp.) causing death or overt toxicity, requiring the target of the 
remaining peptides to be carefully determined. 
AVIT family proteins are distributed widely in mammalian tissues and have been shown to cause a 
variety of actions. These include intestinal contraction [39], hyperalgesia [32, 34], spermatogenesis [48], 
protection of neuronal cells from apoptosis [31], control of behavioral circadian rhythms [5] and 
stimulation of endocrine gland angiogenesis [23-26]. In particular MIT1, Bv8 and the prokineticins have 
all been shown to potently stimulate contraction of guinea-pig ileum smooth muscle with EC50 values in 
the low to subnanomolar range [27, 32, 39]. However, they do not affect a range of other smooth muscle 
preparations including vas deferens, trachea, aorta, uterus, and gallbladder. Recent studies have shown 
that PK1 and PK2 are cognate ligands for two G-protein-coupled receptors designated ZAQ (PK1 
receptor; PKR1) and I5E (PK2 receptor: PKR2), respectively [28, 29]. PK1 and PK2 induce a transient 
increase in intracellular calcium ([Ca2+]i) with nanomolar potency in Chinese hamster ovary (CHO) cells 
and human embryonic kidney (HEK293) cells expressing PKR1 and PKR2 receptors [28, 29]. They bind 
to these receptors with high affinity but PK2 has a higher affinity for both receptors than PK1. 
In the present study we have identified six novel MIT-like ACTX orthologs using a combination of 
HPLC and molecular biology techniques. Given the homology to the AVIT protein family, we 
hypothesized that ACTX-Hvf17 and these MIT-like spider venom peptides stimulate nociceptors and 
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gastrointestinal motility. Thus, these peptides may be useful compounds in the development of 
prokinetic agents in the treatment of conditions involving poor gastrointestinal motility, or novel 
analgesics. We show that while ACTX-Hfv17 shares sequence homology to AVIT family proteins and 
conforms to a similar ancestral protein fold, known as the disulfide-directed -hairpin, it lacks the ability 
to stimulate vertebrate gastrointestinal smooth muscle contractility. It also fails to bind to prokineticin 
receptors that mediate hyperalgesia and the prokinetic actions on smooth muscle. Modeling of the 3D 
structure of the MIT-like ACTX family and AVIT family proteins, based on the known structure of 
MIT1, revealed that the surface charges were also significantly different between these two families of 
peptides suggesting that the two families may target different receptors and are likely to be functionally 
distinct. 
 
2. Materials and methods 
2.1 Peptide purification 
Venom was collected from both male and female specimens of the Australian funnel-web spider 
species H. sp. 20 (“Illawarra”) and H. versuta, and female specimens of the Orchid Beach variant of H. 
infensa (H. infensa: Orchid Beach) by aspirating venom from the fang-tips (chelicerae) of aggravated 
spiders into polyethylene pipette tips. Collected venom was dissolved in 0.1% TFA (v/v) for sample 
transfer to polyethylene tubes and dried down in a Savant SpeedVac for storage at –20°C.  
ACTX-Hvf17 was isolated from H. versuta venom as described previously [42]. Lyophilized crude 
Hadronyche sp. 20 and H. infensa: Orchid Beach venoms were dissolved in 0.1% TFA (v/v) and 
components purified using an analytical C18 RP-HPLC column (4.6 x 250 mm, 300 Å pore size, 5 Gm
particle size; Vydac, Hesperia, CA, USA). Venom peptides were eluted using an acetonitrile gradient (0-
80% acetonitrile/0.1% TFA over 80 min) at a flow rate of 1 ml/min governed by a Waters 600 
Controller. The UV absorbance was monitored at 214 nm using a Waters 486 tunable absorbance 
detector. Purified peptides were collected in polyethylene tubes, lyophilized, and stored at -20°C until 
required. The molecular mass of each peptide was confirmed by ESI-MS acquired in positive ion mode 
on a PE-SCIEX API III triple quadrupole mass spectrometer (PE-SCIEX, Canada) equipped with an 
Ionspray atmospheric pressure ionization source and a Turbospray facility. The full scan data for each 
venom sample was acquired at an orifice potential of 80 V over a mass range of 400-2100 Da with a step 
size of 0.2 Da. Data is presented as the average mass in Da. 
Toxin quantification was performed using a BCA (bicinchoninic acid) Protein Assay Kit (Pierce, 
Rockford, IL, USA) using BSA as a standard. Absorbances were read at 570 nm on a BIO-RAD Model 
450 microplate reader. 
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2.2 N-terminal amino acid sequencing 
The disulfide bonds of RP-HPLC purified native peptides were reduced using 100 mM TCEP in 100 
mM ammonium acetate (pH 6.5) and heating at 45°C for 1 h. The reduced cysteine residues were 
alkylated using 100 mM maleimide/10% acetonitrile and heating at 45°C for 1 h. The reduced and 
alkylated peptides were isolated by elution on an analytical C18 RP-HPLC column using Vydac 4.6 x 
250 mm (see above) or Zorbax 2.1 x 50 mm (300 Å pore size, 3.5 µm particle size or 80 Å pore size, 5 
Gm particle size; Hewlett Packard, Australia) columns. Partial amino acid sequences of the alkylated 
peptides were determined using Edman degradation chemistry on an Applied Biosystems 477A Protein 
Sequencer in conjunction with an Applied Biosystems 120A Analyser (Applied Biosystems/Perkin 
Elmer, USA). Standard Applied Biosystems sequencing cycles and Perkin Elmer solvents (Applied 
Biosystems/Perkin Elmer) were used. Data collection and analysis was performed using Model 610A 
version 2.0 software (Applied Biosystems/Perkin Elmer) on a Macintosh IIsi computer. 
 
2.3 Enzymic digestion of N-terminally blocked peptide components 
Peptides determined to be N-terminally blocked from preliminary N-terminal amino acid sequencing 
were fragmented by enzymatic digestion with bovine pancreas trypsin (Sigma, Australia). The peptide 
fragments were eluted using an analytical RP-HPLC column (Zorbax 2.1 x 50 mm, 80 Å pore size, 5 
Gm particle size) and an acetonitrile gradient (0-80% acetonitrile/0.1% TFA over 80 min) at a flow rate 
of 200 Gl/min. The solvent delivery and gradient formation was achieved using a Hewlett Packard Series 
1100 HPLC pump system (Hewlett Packard). The UV absorbance of the eluting fragments was 
monitored at 210 nm and 280 nm using a Hewlett Packard Diode Array Detector. Amino acid 
sequencing was performed on an Applied Biosystems 477A Protein Sequencer. 
 
2.4 mRNA Isolation and cDNA library formation 
The venom glands of anaesthetized mature and juvenile male H. sp. 20, and a female H. infensa:
Orchid Beach specimens were dissected and the mRNA purified using a Pharmacia Biotech Quickprep 
Micro mRNA Purification Kit (Pharmacia Biotech, Cleveland, OH). First strand cDNA synthesis from 
the poly-A+ mRNA template of all specimens used a NotI-d(T)18 bifunctional primer {5’- 
AACTGGAAGAATTCGCGGCCGCAGGAAT(18)} (Pharmacia Biotech) extended with Superscript II 
Reverse Transcriptase (Invitrogen, Australia). A 5’ universal adaptor was added to the single-stranded 
cDNA (ssDNA) template library of the juvenile male H. sp. 20 and female H. infensa: Orchid Beach 
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samples employing the Smart cDNA synthesis technology (Clontech Laboratories, Palo Alto, CA, 
USA). The juvenile male H. sp. 20 cDNA template library remained single-stranded. 
Second strand synthesis of the mature male H. sp. 20 sample employed a Marathon cDNA 
synthesis kit (Clontech Laboratories) to yield Marathon adaptor double-stranded cDNA (dsDNA). The 
dsDNA products were cleaned using a BRESAspin PCR Purification Kit (Bresatec, Australia). Second 
strand synthesis of the female H. infensa: Orchid Beach sample was performed by PCR with a Smart
adaptor specific primer {5’-AAGCAGTGGTATCAACGCAGAGT} and Pfu turbo polymerase 
(Stratagene, Cedar Creek, TX, USA) following the thermal cycling protocol; 1 cycle of 95˚C for 1 min, 
25 cycles of 95˚C for 30 s, 60˚C for 30 s, 72˚C for 5 min, and 1 cycle of 72˚C for 10 min. 
 
2.5 Primer design and PCR 
5’ RACE of the mature male H. sp. 20 dsDNA template using AmpliTaq Gold with GeneAmp kit 
(PerkinElmer, Shelton, CT, USA) employed redundant primers 7358-B 
{5’-(TC)TC(AGTC)CC(AG)CA(TC)TC(TC)TG(AG)TC(AGTC)CC} and 7406-B 
{5’-(AG)CA(AGTC)A(AG)(AG)TC(AG)TACAT(TC)TG} based on the partial amino acid sequences 
of the mature peptides ACTX-Hs20f7358 and ACTX-Hs20f7406 and a universal adaptor primer 
(Clontech Laboratories). Thermal cycling followed the cycle protocol; 1 cycle of 95˚C for 5 min, 35 
cycles of 95˚C for 30 s, 50˚C for 1 min, 72˚C for 1.5 min, and 1 cycle of 72˚C for 10 min. PCR products 
were cleaned by agarose gel electrophoresis and then cloned into a pCR 2.1 vector and transformed into 
host INVF’ cells using an Invitrogen TA Cloning Kit (Invitrogen). Sequencing (AGRF, Brisbane, 
Australia) of the derived leader sequence allowed the gene-specific 3’ RACE PCR primers 7358-1A {5’-
CGGCCACCCCTGCACTGAACATGT} and 7406-1A {5’-
TGCTGAAATTTGTAGTACTGATTTGCC} to be designed. These gene-specific primers were used in 
conjunction with a 3’ universal primer (Clontech Laboratories) to amplify coding sequences from the 
cDNA template. Final PCR products (~500 bp) were purified, cloned into a pCR 2.1 vector and 
transformed into host INVF’ cells using an Invitrogen TA Cloning Kit (Invitrogen), and clones 
containing the correct insert size were sequenced (AGRF).  
 
2.6 Expressed sequence tag library 
The PCR products of the female H. infensa: Orchid Beach sample were cleaned on a Bresatec PCR 
purification column, cut with NotI (MBI Fermentas, Hanover, MD, USA), re-cleaned using Bresa-Clean 
matrix (Bresatec), cloned into pGEM 5Zf(+) NotI/EcoRV dephosphorylated vector (Promega, Australia) 
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and transformed into TOP10f’ cells (Invitrogen). Clones containing the correct insert size were 
sequenced (AGRF). 
 
2.7 Molecular modeling 
The ACTX-Hvf17, ACTX-Hi:OB75212, ACTX-Hs20f7358, Bv8, rPK1 and rPK2 models were 
constructed using the Homology program within the Insight II molecular modeling system from 
Accelrys. The amino acid sequences of MIT1 (Boisbouvier et al., 1998), ACTX-Hvf17 (Szeto et al,
2000), ACTX-Hi:OB7512 (this paper), ACTX-Hs20f7358 (this paper), Bv8 [32], rPK1 and rPK2 [29] 
were aligned within Homology where the alignment was refined using predicted structurally conserved 
regions of MIT1 defined by PROMOTIF [15]. Refining the models involved repairing splice points such 
that  angles and corresponding bond distances were 180 ± 1˚ and 1.34 Å, respectively. The models 
were then minimized using steepest descents and conjugate gradients taking into account morse and 
cross terms and charges to a rmsd below 10-6 kcal/mol-Å. Finally, the models were validated using the 
programs Profiles 3D (within the Homology program) and Procheck [33]. 
 
2.8 Isolated smooth muscle preparations 
All animal experimentation was approved by the Animal Care and Ethics Committees of the 
University of Technology, Sydney and Monash University. Given the lack of H. sp. 20 and H. infensa:
Orchid Beach spiders and thus sufficient venom for pharmacological investigations, experiments were 
only carried out with ACTX-Hvf17.  
 
2.8.1 Isolated guinea-pig ileum smooth muscle preparation 
Dunkin-Hartley guinea-pigs (0.5-1.3 kg), of either sex, were sacrificed by dislocation of cervical 
vertebrae. Segments of ileum (2-3 cm), dissected 10 cm distal to the ileo-caecal junction, were then 
dissected and attached to electrodes. These were mounted in 5 ml isolated organ baths in a Krebs 
solution of the following composition (mM): NaCl 118.4, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl2 2.5, 
NaHCO3 25.0 and D-glucose, 11.1. The solution was maintained at 34°C and bubbled with carbogen 
(95% O2 and 5% CO2). For electrically stimulated preparations, ilea were transmurally stimulated by 
regular field pulses (40 V, 0.5 ms, 0.2 Hz) using a Grass S88 stimulator.  
 
2.8.2 Isolated rat stomach fundus and aorta smooth muscle preparations 
Adult male Wistar rats (300-350 g) were sacrificed by dislocation of cervical vertebrae. The stomach 
and aorta were removed and placed in a Krebs solution of the following composition (mM): NaCl 119, 
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KCl 4.7, MgSO4 1.0, CaCl2 2.5, NaHCO3 25.0, KH2PO4 1.2 and D-glucose 11.1. The solution was 
maintained at 37°C and bubbled with carbogen (95% O2 and 5% CO2). The fundus portion of the rat 
stomach was divided in half by making a midline incision along the greater curvature. The mucosa was 
carefully excised. A medial longitudinal strip (3 x 15 mm) was obtained from each half of the divided 
fundus by making cuts parallel to the midline incision. Rat aortas were removed from the section of the 
thoracic aorta between the aortic arch and the diaphragm. Spiral strips (2 x 15 mm) were obtained from 
the aorta and cleaned of adhering fat and connective tissue. Tissues were then placed in 10 ml organ 
baths.  
 
2.8.3 Contractility studies 
Isometric muscle tension was recorded with a force-displacement transducer (Nihon Kohden SB-1T, 
Tokyo, Japan) on a polygraph (Nihon Kohden) or a Grass transducer (FTO3) connected to a Grass 
polygraph (Model 79D). Data were also digitized using a MacLab 4/s or Powerlab/400 data acquisition 
system (ADInstruments, Castle Hill, Sydney, Australia). Each preparation was placed under an initial 
resting tension of 1 g and allowed to equilibrate for 1 h before experimental procedures were carried out. 
Muscle tension in each tissue was recorded in the absence of additives or following injection of peptides 
(5–20 Gl in water) directly into the bath buffer. To confirm stable contractions of sufficient amplitude, 
contractions of smooth muscle preparations to 1 GM ACh (ileum and fundus) or 50 mM KCl (aorta) 
were checked before addition of ACTX-Hvf17 or vehicle, and at the conclusion of the experiment. To 
determine if ACTX-Hvf17 blocked contractions mediated via prokineticin receptors, responses to 
recombinant hPK1 (Peprotech, Princeton, NJ, USA) were measured before, and following, addition of 
ACTX-Hvf17. 
 
2.9 Calcium-mobilization assay using a fluorometric imaging plate reader (FLIPR) 
Assessment of ACTX-Hvf17 function on prokineticin receptors was accomplished using a 
fluorometric imaging plate reader assay (FLIPR, Molecular Devices, Sunnyvale, CA, USA). Briefly, 24 
h prior to experimentation, HEK293 cells stably expressing human prokineticin 1 (hPKR1) or human 
prokineticin 2 (hPKR2) receptors were plated into clear bottom, black-walled 96-well plates precoated 
with poly-D-lysine (Becton-Dickinson, Franklin Lakes, NJ, USA) at a density of 5 x 105 cells per well. 
The cDNAs encoding hPKR1 and hPKR2 receptors were obtained by PCR from genomic DNA using 
primers based on the publicly available sequences (GenBank accession numbers AF506287 and 
AF506288, respectively). The cDNAs were expressed from the pCDNA3.1 vector (Invitrogen, Carlsbad, 
CA, USA). On the day of screening, cells were loaded using the calcium 3 assay kit (Molecular Devices) 
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according to the manufacturer's protocol. ACTX-Hvf17 was added at the indicated concentrations and 
the elevation in fluorescence, in proportion to an increase in [Ca2+]i, was monitored. In cases where 
ACTX-Hvf17 was tested for antagonist activity the initial exposure to the spider peptide was followed 
five minutes later by the introduction of 10 nM recombinant hPK1 (Peprotech). 
 
2.10 Chemicals 
Unless otherwise stated, all chemicals were of analytical grade and were purchased from 
Sigma-Aldrich Chemical Co. (St Louis, MO, U.S.A.). 
 
2.11 Statistical analysis 
Numerical data are presented as the mean ± S.E. (n, number of observations). Statistical differences 
were determined using a Student’s paired t-test, at P < 0.05.
3. Results 
3.1 Isolation of a novel family of spider peptides with sequence homology to the MIT-like ACTX-Hvf17 
Components of H. sp. 20 (“Illawarra”) funnel-web spider venom with Mr ~7400 Da were sequenced 
employing Edman degradation in conjunction with molecular biology techniques. Initially, three 
peptides, with Mr of 7357.8, 7406.2 and 7390.0 Da, were isolated from the venom by RP-HPLC (Fig. 
1A) and subjected to automated N-terminal amino acid sequencing. An additional small peak with a Mr
of 7496.2 Da was also noted in the HPLC chromatograms but not subjected to N-terminal amino acid 
sequencing. The peptide component with a Mr of 7357.8 Da yielded a partial 37-residue N-terminal 
sequence. This sequence information displayed significant homology to the MIT-like molecule 
ACTX-Hvf17 from the venom of H. versuta (Fig. 2B). This MIT-like atracotoxin molecule was named 
ACTX-Hs20f7358 following the nomenclature system for atracotoxins (ACTX, [11]), where the suffix 
‘Hs20’ represents the Genus and species name and ‘f7358’ represents the venom HPLC fraction with Mr
7357.8. However, the remaining two components with Mr of 7406.2 and 7390.0 Da failed to yield any 
sequence information suggesting that both molecules are blocked at the N-terminus or possess a cyclic 
peptide backbone. Subsequently, the fraction with a Mr of 7406.2 Da was subjected to enzymatic 
digestion with trypsin. Two resulting fragments were isolated by RP-HPLC and sequenced by automated 
N-terminal amino acid sequencing. Only one digestion fragment sequenced successfully and yielded an 
eight-residue sequence LSQMYDLC showing homology to residues 25-32 in ACTX-Hvf17 (Fig. 3) and 
ACTX-Hs20f7358 (Fig. 2B & 3). This fraction was therefore named ACTX-Hs20f7406. 
Based on the retention time and molecular weight similarities, the molecule with a Mr of 7390.0 Da 
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was predicted to be an isoform of the 7406.2 Da component. As a result it was anticipated that both 
components would be identified from the use of a single 3’ RACE primer. Due to the expected sequence 
characterisation of both components in the molecular biology experiments, enzymatic digestion was not 
performed on the 7390.0 Da fraction. 
 
3.2 Sequence identification of MIT-like ACTX peptides using RACE 
A cDNA library was used in the identification of these Hadronyche sp. 20 (“Illawarra”) venom 
components. A redundant 5’ RACE primer (7406-B) was constructed based on the partial N-terminal 
sequence information obtained from the tryptic digest fragment of ACTX-Hs20f7406. PCR experiments 
of the male H. sp. 20 cDNA template library with the 5’ RACE primer generated a DNA product of 
approximately 210-250 bp in length. The cloning and subsequent sequencing of three clones of products 
derived from the H. sp. 20 cDNA library yielded N-terminal sequence information of the mature peptide 
and a short leader sequence. The short leader revealed evidence of a 54 bp signal peptide, but no 
evidence of a propeptide sequence. The absence of a propeptide sequence is in contrast to other 
nucleotide sequences identified from the venom ducts of Australian funnel-web spider species [41].  
PCR experiments performed on the H. sp. 20 cDNA template library with a second 5’ RACE primer 
(7358-B) designed on the partial amino acid sequence obtained for ACTX-Hs20f7358 provided a DNA 
product of approximately 160-200 bp in length. Cloning and subsequent sequencing provided similar 
leader sequence information to that obtained for ACTX-Hs20f7406, but differed by 6 bp.  
The combined leader sequence information derived from the 5’ RACE experiments on the H. sp. 20
cDNA template library was used to design two gene specific 3’ RACE primers (7406-1A and 7358-1A) 
to allow determination of the complete coding sequences of Mr 7357.8, Mr 7406.2 and Mr 7390.0. 
Cloning and subsequent sequencing of multiple clones of the corresponding DNA products derived from 
the H. sp. 20 cDNA template library identified five MIT-like molecules. The amino acid sequences of 
the five identified molecules show homology to the peptide ACTX-Hvf17 isolated from the venom of 
Hadronyche versuta [42]. The cDNA sequences derived for the MIT-like components from the H. sp. 20
library consist of coding sequences of 267 bp and 252 bp translating to 89 and 84 amino acids 
respectively. The 7406-1A gene specific 3’ RACE primer was designed to maximize the number of base 
pair differences between the ACTX-Hs20f7358 and ACTX-Hs20f7406 leader sequences to allow 
differential selection of the two sequences by variation of the annealing temperature during PCR. The 5’ 
end of the primer corresponds to the T of the translation start codon (ATG – coding for Met) and as such 
nucleotide sequences obtained from this primer have an incomplete start codon. Since it is known the 
first two nucleotides of sequences obtained from the 7406-1A primer are part of the start codon, the 
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amino acid sequences are taken to include Met for the sake of completeness. The predicted mature 
peptide sequences comprise 71 and 66 amino acids respectively and contain a 10 cysteine framework 
forming five disulfide bonds.  
 
3.3 Post-translational C-terminal processing and N-terminal block of MIT-like ACTX 
Examination of the mature peptide sequences derived from the 7406-1A 3’ RACE primers revealed 
theoretical calculated molecular weights of 7779.5, 7795.5, 7807.6, 7358.1 and 7868.8 Da, when 
accounting for the presence of five disulfide bonds. The presence of the molecule ACTX-Hs20f7358 
(GenBank accession number AY914165) was easily identified in the RP-HPLC/ESI-MS data (Fig. 1A) 
and the sequence obtained matched the partial sequence information collected from N-terminal amino 
acid sequencing of native material. No molecules with molecular weights of 7779.5, 7795.5, 7807.6 or 
7868.8 Da were identified in the RP-HPLC/ESI-MS profile of the H. sp. 20 venom. Further observation 
of the sequences predicted that the discrepancy in molecular weight was the result of a post-translational 
cleavage of the C-terminal residues, Arg-Ser-Glu. Post-translational C-terminal “trimming” has been 
reported for a number of peptide toxin components, including spider [9, 17], bee [20], cone snail [6] and 
scorpion [3] toxins. The respective molecular weights of the four components following removal of the 
C-terminal fragment (RSE) are 7407.1, 7423.1, 7435.2 and 7496.4 Da. A molecule of molecular weight 
7496.2 Da (ACTX-Hs20f7496, GenBank accession number AY914164) is evident in the RP-HPLC/ESI-
MS data (Fig. 1A) and elutes close to the two components with Mr of 7406.2 and 7390.0 Da.  
The failure of the N-terminal amino acid sequencing experiments performed on the two molecules 
with Mr of 7406.2 and 7390.0 Da is most likely accounted for by the presence of N-terminal Gln 
residues. The three 7407.1, 7423.1 and 7435.2 Da components have an N-terminal Gln, a residue known 
to commonly form pyroglutamate and block N-terminal sequencing. The formation of pyroglutamate 
from Gln results in the loss of NH3 corresponding to a mass of 17 Da. A further recalculation of the 
masses of the three components, allowing for the C-terminal trimming and pyroglutamate formation, 
reveals respective molecular weights of 7390.1 Da (ACTX-Hs20f7390, GenBank accession number 
AY914166), 7406.1 Da (ACTX-Hs20f7406, GenBank accession number AY914168) and 7418.1 Da 
(ACTX-Hs20f7418, GenBank accession number AY914167). The two components ACTX-Hs20f7390 
and ACTX-Hs20f7406 were easily identified in the RP-HPLC/ESI-MS data (Fig. 1A), however the third 
component ACTX-Hs20f7418 was not evident. It is possible that the component ACTX-Hs20f7418 is 
expressed at levels below the level of detection on the mass spectrometer and as a result is not evident in 
the RP-HPLC/ESI-MS data.  
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3.4 The Expressed Sequence Tag (EST) technique identified the presence of a MIT-like ACTX in the 
venom of Hadronyche infensa: Orchid Beach. 
During the course of the studies on MIT-like ACTX components, a further component belonging to 
this family, ACTX-Hi:OBf7512 (GenBank accession number AY914163), was identified from the 
venom glands of a female Hadronyche infensa: Orchid Beach specimen using Expressed Sequence Tag 
(EST) techniques (Fig. 2A). The sequence information provided a mature peptide sequence containing 
an identical C-terminal tail (Arg-Ser-Glu) to some of the sequences of this family derived from the 
RACE experiments (Fig. 2B). It was anticipated, based on molecular weight calculations, that these C-
terminal residues were post-translationally cleaved to produce the mature product. 
The calculated theoretical molecular weight of the fully cleaved mature product, accounting for the 
formation of five disulfide bonds and C-terminal tail cleavage, was 7586.5 Da. This molecular weight is 
not observed in the RP-HPLC/ESI-MS data, however the sequence does contain an N-terminal Gln 
residue that, based on the ACTX-Hs20 molecules identified, is predicted to form pyroglutamate. A 
recalculation of the molecular weight, allowing for pyroglutamate formation, arrived at a molecular 
weight of 7569.5 Da. No molecules of this mass were observed in the Hadronyche infensa: Orchid 
Beach venom profile. It was noted that the mature sequence, following removal of the Arg-Ser-Glu C-
terminal tail, was one residue (Gly) longer than the other sequences predicted to involve identical C-
terminal trimming. Furthermore, cleavage of the C-terminal Gly residue from other toxins has been 
reported to form a C-terminal amide [3, 6, 20]. Removal of the Gly results in a molecular weight of 
7512.4 Da, and a peak corresponding to this molecular weight is evident in the RP-HPLC/ESI-MS 
chromatogram labeled ACTX-Hi:OBf7512 (Fig. 1B). It is also possible that the cleavage of the Gly 
forms a C-terminal amide, to yield a component having an Mr of 7511.5 Da. Precision mass data was not 
collected on native material of the component and therefore the exact molecular weight and the 
possibility of a C-terminal amide has not been conclusively resolved. 
A comparison of the MIT-like ACTXs revealed that these molecules constitute two groups. The first 
of these groups consists of the 66-residue peptide, ACTX-Hs20f7358, which does not undergo any 
primary sequence post-translational modifications. The second group is composed of the 68-residue 
components, ACTX-Hvf17 and its ACTX orthologs -Hs20f7406, -Hs20f7390, -Hs20f7418, -Hs20f7496, 
and Hi:OBf7512, and demonstrates post-translational C-terminal trimming of a propeptide to yield the 
mature product (although this is not known for ACTX-Hvf17). A blastp search of the Swiss-
Prot/TrEMBL knowledgebase revealed high sequence homology of the MIT-like ACTX with 
ACTX-Hvf17, two non-toxic spider peptides from the venom of the spider P. reidyi, and to a lesser 
extent, AVIT family proteins (Fig 3). 
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3.5 Effect of ACTX-Hvf17 on gastrointestinal and vascular smooth muscle 
Previously, ACTX-Hvf17 has been screened for mammalian bioactivity using a rat vas deferens 
bioassay [42]. In this previous study it was found that the peptide lacked any observable activity in this 
smooth muscle preparation. Given the potential activity of the peptide on other smooth muscle 
preparations, particularly gastrointestinal tissue, the present study therefore tested the activity of ACTX-
Hvf17 on isolated ileum and stomach fundus, as well as aorta. As shown in Fig. 4, ACTX-Hvf17 at 
concentrations up to 1 GM had no effect on gastrointestinal smooth muscle. This was evidenced by a 
lack of change in resting (baseline) tension of isolated guinea-pig ileum longitudinal muscle (n = 3; Fig. 
4Ab) and rat stomach fundic muscle strip preparations (n = 6; Fig. 4B). In addition, ACTX-Hvf17 failed 
to alter stimulated contractions of guinea-pig ileum (n = 3; Fig. 4Aa). Furthermore, ACTX-Hvf17 (1 
GM) failed to affect the resting tension of isolated aortic smooth muscle preparations (n = 3, Fig. 4C) 
indicating that the peptide does not directly stimulate vascular smooth muscle.  
To investigate the possible antagonism of prokineticin receptors by ACTX-Hvf17, smooth muscle 
strips from rat stomach fundus and guinea-pig ileum were contracted with hPK1 and ACTX-Hvf17 
added 10 min before a second challenge of hPK1. At concentrations of hPK1 up to 10 nM, hPK1 only 
caused contractions in 3 out of 6 fundic strips. The contractile responses in these 3 tissue strips were 
only around 20% of the responses elicited by 1 GM ACh. In addition, following the first application of 
hPK1, a strong tachyphylaxis developed such that additional applications of hPK1 did not result in any 
contraction. It was thus not possible to obtain a reproducible response to hPK1 in these preparations. 
This strong tachyphylaxis supports the observation by Mollay et al. (1999) who demonstrated that an 
intense tachyphylaxis developed after the first exposure of MIT1 and Bv8 to jejunum and colon. In 
contrast, hPK1 produced reproducible dose-dependent responses in guinea-pig ileum. However, 
concentrations of ACTX-Hvf17 up to 1 GM failed to alter the amplitude of these contractions, signifying 
that the peptide does not block prokineticin receptors in guinea-pig ileum (P > 0.9, n = 3; Fig. 4Ac). 
 
3.6 Effects of ACTX-Hvf17 on expressed prokineticin receptors 
To directly evaluate the effect of ACTX-Hvf17 on prokineticin receptors, we assessed the increase in 
[Ca2+]i in HEK293 cells stably expressing hPKR1 or hPKR2 receptors using a fluorometric imaging 
plate reader (FLIPR) assay. In this assay hPK1 (Fig. 5A) caused a dose-dependent transient increase in 
[Ca2+]i. Initial experiments were designed to identify any potential agonist activity. As with the isolated 
smooth muscle preparations, concentrations of ACTX-Hvf17 up to 100 nM failed to evoke an increase 
in [Ca2+]i in cells expressing either hPKR1 (Fig. 5A) or hPKR2 receptors (data not shown). 
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Consequently, we examined the antagonist activity of ACTX-Hvf17 on prokineticin-induced increases 
in [Ca2+]i. Cells expressing hPKR1 or hPKR2 receptors were incubated with 10 nM hPK1 together with 
increasing concentrations of ACTX-Hvf17. Concentrations of ACTX-Hvf17 as high as 100 nM failed to 
inhibit hPK1-induced transient increases in [Ca2+]i (Fig. 5B). These data indicate that ACTX-Hvf17 
lacks both agonist and antagonist activity at hPKR1 and hPKR2 receptors.  
 
3.7 Molecular modeling of MIT-like ACTX 
The 3D structures of the MIT-like ACTXs, Bv8, PK1 or PK2 have not yet been solved. ACTX-
Hvf17 aggregates under a wide variety of solvent conditions at concentrations sufficient for NMR 
making NMR structural analysis futile [42], whereas structural analysis on the other peptides has not yet 
been attempted. However, the 3D structure of MIT1 has been determined (Fig. 6A) and despite a low 
level of sequence homology, was found to be very similar to porcine colipase [2, 45]. Given the overall 
sequence homology between MIT-like ACTX, Bv8, PK1, PK2, MIT1 and to a lesser extent colipase, 
including the conserved cysteine residues and resistance to proteolytic digestion [2], MIT-like ACTX, 
Bv8, PK1 and PK2 were proposed to have the same 3D folds as MIT1 and colipase [42]. Modeling of 
the ACTX-Hvf17, ACTX-Hi:OBf7512, ACTX-Hs20f7358, Bv8, rPK1 and rPK2 structures based on 
MIT1, as shown overlaid in Fig. 6B (ACTX-Hvf17 only), reveals that the structurally conserved regions 
of the putative 3D structure of ACTX-Hvf17, ACTX-Hi:OBf7512, ACTX-Hs20f7358, Bv8, rPK1 and 
rPK2 are indeed very similar to those of the MIT1 and colipase peptides. This is not surprising given 
that all 10 cysteine residues align closely between the eight peptides even though the primary sequence 
is not identical in length. Additionally, loop 3 in all peptides aligns well to MIT1 having an rmsd over 
the backbone atoms of approximately 0.36 Å. However, models displaying the electrostatic surface 
potential revealed that MIT-like ACTX peptides do not share similar surface charge distribution as 
AVIT family proteins (Fig. 6C-D). In addition, while the AVIT family proteins share a comparable 
surface polarity distribution the MIT-like ACTX peptides do not (Fig. 6C-D). 
 
3.8 ACTX-Hvf17 conforms to the DDH ancestral protein fold 
Previously, MIT1, colipase, and a wide variety of other eukaryotic proteins, have been characterized 
as comprising a disulfide-directed -hairpin (DDH) fold [47], as shown in Fig. 7Aa. The amino acid 
consensus sequence of the DDH fold can be written as CX5-9CX2[G or P]X2CX6-19C, where X is any 
amino acid [47]. A strictly conserved central Gly or Pro is also present in loop 3, which ensures a tight 
turn prior to the first -stand (Fig. 6A-B). In general, hydrophobic residues also tend to follow the 
central Gly/Pro in loop 3. The inhibitor cystine-knot (ICK) motif present in all ACTX structures 
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determined to date appears to have evolved from this simpler ancestral fold [47]. In contrast to the ICK 
motif, which has not been found in vertebrates and includes a triple-stranded antiparallel -sheet (Fig. 
7Ab), the DDH fold is found in a variety of eukaryotes, has no requirement for an N-terminal -strand, 
and only two mandatory disulfide bridges form the bulk of the hydrophobic core of this domain. 
Importantly, we observed a homologous DDH domain in all the MIT-like ACTX and the P. reidyi spider 
peptides PRTx16C0 and PRTx16C1 (Fig. 7B). In addition, there is a strong conservation of residues in 
loop 3 between the MIT-like ACTX, the P. reidyi spider peptides and the AVIT family of proteins with 
a consensus sequence of CGXGXCC, where X is any amino acid. Therefore it appears that MIT-like 
ACTXs, PRTx16C0, PRTx16C1, Bv8, MIT1, and the various prokineticins may have arisen from 
simple gene duplication followed by minor residue changes in the intervening loops (Fig. 7B). In the 
case of MIT-like ACTXs and the P. reidyi peptides, however, they appear to have undergone the 
greatest alteration or deletion of loop residues, particularly in the N-terminal and loop 4 regions, 
resulting in loss of activity on prokineticin receptors. 
The DDH motif of the MIT-like ACTX differs from other DDH members by having only four 
residues following the first cysteine in the amino acid consensus sequence. Furthermore, huwentoxin-II 
(Shu et al., 2002), another spider peptide conforming to the DDH fold, only has four residues preceding 
the last cysteine in the amino acid consensus sequence (Fig. 7B). Hence the consensus sequence needs to 
be modified to CX4-19CX2[G or P]X2CX4-19C. However, the presence of five residues in loop 3 with a 
central Gly residue in virtually all cases, exclude the possibility that the MIT-like ACTXs adopt the 
cystine-stabilized -sheet (CSB) motif [14]. In the CSB fold the number of residues in loop 3 can be as 
low as two and there is no requirement for a central glycine residue. 
 
4. Discussion 
Through a combined approach of amino acid sequencing and molecular biology techniques, five 
homologous components were isolated from the venom of H. sp. 20. An additional ortholog was also 
identified from the venom of H. infensa: Orchid Beach using EST molecular biology techniques. With 
the exception of the component ACTX-Hs20f7418 from H. sp. 20 venom, all molecules were accounted 
for in their respective venom RP-HPLC/ESI-MS profiles (Fig. 1). This family of peptides shows high 
amino acid sequence homology with each other particularly in the leader sequence (Fig. 2B). In addition, 
they all show high sequence homology with ACTX-Hvf17 from H. versuta venom [42] and to a lesser 
extent PRTx16C0 and PRTx16C1 from the venom of the spider P. reidyi. Like ACTX-Hvf17, the target 
of these peptides and those from P. reidyi venom is yet unknown. 
ACTX-Hvf17, and the orthologous peptides identified in the present study, also show significant 
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sequence homology with MIT1. Hence we have termed this group of non-toxic atracotoxins the ‘MIT-
like’ ACTX family. MIT1 belongs to the ‘AVIT’ protein family including Bv8 and orthologs from the 
PK1/EG-VEGF and PK2 families [19]. All AVIT family members that have been tested so far stimulate 
contraction of fundus and ileum smooth muscle via interaction with prokineticin receptors. Therefore, 
we determined if MIT-like ACTX interacted with prokineticin receptors to increase gastrointestinal 
smooth muscle contractility. 
Unlike AVIT proteins, this study showed that the prototypical MIT-like ACTX, ACTX-Hvf17, does 
not stimulate gastrointestinal smooth muscle contractility as evidenced by a lack of activity on 
stimulated guinea-pig ileum and rat stomach fundus. Neither did the peptide affect responses of ileum 
smooth muscle to ACh. In addition, the peptide failed to contract other smooth muscle preparations 
including rat aorta. We also assessed the ability of ACTX-Hvf17 to act as a prokineticin receptor 
antagonist by determining the ability of the peptide to inhibit hPK1-induced contractions of 
gastrointestinal smooth muscle. We were unable to assess the effects on hPK1-induced contractility in 
fundus and aorta due to the inconsistent response and strong tachyphylaxis of hPK1 in these tissues. 
Nevertheless, ileal muscle contractions elicited by 4 nM hPK1 were unaffected by 1 GM ACTX-Hvf17. 
In addition to experiments performed on isolated smooth muscle, we also investigated the effects of 
ACTX-Hvf17 on hPKR1 and hPKR2 receptors expressed in HEK293 cells. These are orphan G-protein-
coupled receptors that are present on various mammalian cells and were found to bind AVIT family 
proteins. Receptor activation leads to an increase in [Ca2+]i, as well as an increased phosphoinositide 
turnover, and activation of the p44/p42 mitogen-activated protein kinase signaling pathway (for a review 
see [19]). These actions are consistent with the effects of prokineticins on smooth muscle contractility 
and angiogenesis. Using a FLIPR assay, ACTX-Hvf17 at concentrations up to 100 nM failed to cause an 
increase in [Ca2+]i indicating that the peptide lacks agonist activity on both hPKR1 and hPKR2 receptors. 
In addition, increasing concentrations of ACTX-Hfv17 up to 100 nM failed to inhibit the hPK1-induced 
increase in [Ca2+]i signifying that ACTX-Hf17 lacks antagonist activity on both PKR1 and PKR2 
receptors. In concert, the results from the FLIPR assay and isolated smooth muscle preparations indicate 
that ACTX-Hvf17 does not bind to either PKR1 or PKR2 receptors despite sequence homology to the 
AVIT family proteins. The PK2 protein is not commercially available so we were unable to test this 
protein in these assays. It therefore remains a possibility that ACTX-Hfv17 can block the PK2 
interaction with the receptors, although this is unlikely given the overlap in efficacy of PK1 and PK2 at 
prokineticin receptors. It is also possible that prokineticin receptors exist in prey species that differ 
significantly from those found in vertebrates and that the MIT-like peptides show phyla-specificity for 
these targets. Nevertheless no overt toxicity or behavioural changes were noted following injection of 
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ACTX-Hvf17 into crickets, and thus this is improbable.  
Modeling of the electrostatic surface potential of the MIT-like ACTX family based on the known 
structure of MIT1 reveals that the surface charge distribution is distinct from the AVIT family. Indeed, 
while the surface charge distribution within the AVIT family appear to be comparatively similar, the 
electrostatic surface maps of the MIT-like ACTX family appear quite inconsistent between members. 
This adds further support to the finding that the MIT-like ACTX fail to bind to PKR1 or PKR2 receptors. 
Interestingly, one notable sequence characteristic of these MIT-like arachnid venom peptides is that they 
all appear to lack the characteristic N-terminal AVITG[A or V]C sequence of AVIT proteins, suggesting 
a functional role for this region. Furthermore, there is considerable lack of sequence homology in loop 4 
(e.g. Ser15-His21 in ACTX-Hvf17). Unfortunately little is known about the structure-function 
relationships of AVIT protein family members, however it is unlikely that the C-terminal domain plays a 
significant role in the activity of this family of peptides since there is considerable sequence variability 
in the C-termini beyond the last Cys residue. It is also unlikely that the residues in loop 3 are important 
for activity given the high homology with the inactive ACTX-Hvf17 peptide. Experiments with N-
terminal truncates could therefore help to address any functional importance of the N-terminus, 
especially the first five to six residues, of the AVIT family of proteins.  
Given the likelihood that these venom peptides and the AVIT proteins share the ancestral DDH fold 
motif it is conceivable that the two groups, and other proteins such as colipase, evolved from a very 
ancient ancestor. However, following the period of the chordate-arthropod divergence around 1000 
million years ago [46], the mutations in the primary sequence, possibly in the N-terminus and/or loop 4, 
resulted in the loss of activity on prokineticin receptors. These could be due to positive selection for 
adaptive changes as part of a general evolution of the gastroenteropanceatic hormonal system in 
mammals. That is why the functional constraints for the AVIT proteins are practically unchanged in all 
lineages. Nevertheless, an alternative theory is that spider peptides and AVIT proteins evolved 
separately. Given that the DDH fold is present in plants (e.g. gurmarin) as well as invertebrates (e.g. 
spider venom peptides) it can be argued that they evolved independently rather than from a pancreatic 
origin as suggested by Boisbouvier et al. (1998). In support ACTX-Hvf17, colipases, and MIT1 are 
highly resistant to proteases and convergent evolution may have arisen because the DDH fold is an 
efficient way to construct a tight globular protein that is resistant to proteolysis. This has been as 
previously argued for the more elaborate, but related, ICK motif [10] (Fig. 7Ab).  
Based on the partial N-terminal sequencing data of ACTX-Hs20f7358 and the published sequence of 
ACTX-Hvf17 [42], cleavage of the mature peptides from the leader sequences is expected to occur 
following the residues Ser-Ala for the components ACTX-Hs20f7418, ACTX-Hs20f7406 and ACTX-
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Hs20f7390 and residues Phe-Ala for molecules ACTX-Hi:OBf7512, ACTX-Hs20f7358 and ACTX-
Hs20f7496 (Fig 2B-C). These cleavage sites are different to the “classical” prohormone cleavage 
recognition site Lys-Arg between a propeptide and mature-peptide [38], but are consistent with the 
signal peptide cleavage sites predicted using SignalP (v3.0) [1] and those of the AVIT peptide family 
[32, 48]. Importantly, this leader sequence configuration is unlike other neurotoxic ACTX belonging to 
the -1, -1, -2 and 	
1 ACTX families [41], where the leader sequence comprises of a signal 
sequence followed by a propeptide, with the propeptide being cleaved to form the mature-peptide. 
Although no literature reports of mature-peptide cleavage following the residues Ser-Ala were found, 
cleavage of the mature-peptide from the leader sequence for the spider venom peptide latrodectin from 
the Mediterranean black widow spider (Latrodectus tredecimguttatus) was found to occur following the 
residues Phe-Ala [37]. The latrodectin leader sequence is identical in length and similar in sequence to 
the leader sequence of the MIT-like ACTX family; 28% identity increasing to 67-78% homology if 
conservative substitutions are included. Numerous examples of leader sequences composing only a 
signal peptide have also been reported for scorpion toxins [3]. Despite the homology shared in the leader 
sequences, the mature MIT-like ACTX peptide sequences have no notable homology with the mature 
latrodectin sequence. It is also notable that, like the MIT-like A TX family, no functional activity has 
been determined for latrodectin. The leader sequences of Bv8 and its mammalian orthologs hBv8 and 
mBv8 also lack a propeptide region and display some sequence similarity with the leader sequences 
determined for MIT-like ACTX peptides, however they are more variable than the leader sequence for 
latrodectin (17-22% identity, and 39-56% similarity if conservative substitutions are included)[32, 48]. 
All the novel peptide components, except ACTX-Hs20f7358, were concluded to undergo 
post-translational modifications involving N-terminal pyroglutamate formation and/or C-terminal 
“trimming”. Despite this not being reported for other ACTX peptides, post-translational pyroglutamate 
formation has been described with contulakin-G from the cone snail Conus geographus [7], several 
members of the charybdotoxin-like -KTx 1 subfamily of scorpion toxins (for a review see [44]) and 
dendrotoxin from the mamba Dendroaspis augusticeps [8]. C-terminal trimming has also been reported 
for a number of peptide toxin components, including the spider toxins Tx1, Tx3-2 and Pn3A from the 
Brazilian armed spider P. nigriventer [9, 17], the bee toxin melittin [20], -CTX GVIA from C. 
geographus [6] and the scorpion toxins AaHI, AaI’, AaHII and AaHIII [3] from the scorpion 
Androctonus australis hector.
In conclusion, we report the identification of a group of novel atracotoxin peptides, the MIT-like 
ACTX family, with novel leader sequence structure that appear to undergo post-translational 
modification. The results of the present study also illustrate that the prototypical MIT-like atracotoxin, 
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ACTX-Hvf17, does not increase smooth muscle contractility. This finding, coupled with a previous 
report that it does not act as a colipase [42], suggest that the peptide and other MIT-like ACTXs are not 
involved in prey digestion. In addition, the finding that the peptide fails to interact with prokineticin 
receptors, targeted by AVIT family proteins negates the possibility that MIT-like ACTX act as 
hyperalgesic agents to sensitize nociceptors and increase pain in prey species [32, 34]. Modeling of the 
3D structure of the MIT-like ACTX and AVIT family proteins also indicates that these two groups do 
not share similar surface distribution, further supporting the finding that MIT-like ACTX lack affinity 
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Figure Legends 
Fig. 1. RP-HPLC chromatograms of MIT-like ACTX spider peptides. RP-HPLC chromatograms of 
whole venoms from (A) a single juvenile H. sp. 20 (“Illawarra”) (B) an adult female H. infensa: Orchid 
Beach and (C) pooled adult male and female H. versuta, indicating MIT-like ACTX components. 
 
Fig. 2. Nucleotide and corresponding amino acid sequences of MIT-like ACTX. (A) Nucleotide 
identities are boxed in black, with the start, peptide N-terminus and stop codons boxed in grey. (B) 
Amino acid identities boxed in grey with conservative substitutions in grey italic text. (C) Schematic 
representation of the leader peptide, mature peptide and C-terminal tail proposed to be 
post-translationally cleaved (shaded box). 
 
Fig. 3. Sequence alignment of MIT-like ACTX spider peptides with the AVIT protein family. 
Sequence identities relative to ACTX-Hvf17 are shown in grey boxes, while conservative substitutions 
are in grey italic text. Lines connecting pairs of Cys residues above the sequences indicate the disulfide 
bonds determined for MIT1. Abbreviations: PRTx16C0 and PRTx16C1, non-toxic peptides from the 
spider P. reidyi (SWISS-PROT data bank accession numbers P83893 and P83997); Bv8 and Bm8, skin 
secretion proteins from the toad Bombina variegata and B. maxima, respectively [4, 21, 32]; MIT1 [16, 
39]; PK1 and PK2, prokineticin 1 and 2, respectively. Prefixes: r, rat [29]; m, mouse; and h, human [22, 
27, 48]; b, bovine (GenBank accession number AY192558) and f, fugu (see [19]). All mammalian and 
piscine prokineticin sequences are deduced from cloned cDNAs. The lower right table shows the peptide 
length as well as % identity and homology (including conserved substitutions) relative to ACTX-Hvf17.  
 
Fig. 4. Effects of ACTX-Hvf17 on smooth muscle contractility. (A-C) Typical smooth muscle 
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tension traces showing lack of effect of ACTX-Hvf17 on (Aa) field stimulated guinea-pig ileum 
longitudinal muscle, (Ab) hPK1 responses in guinea-pig ileum longitudinal muscle, (B) rat stomach 
fundus longitudinal muscle, and (C) rat aortic strips. Markers beneath each trace indicate the bath 
application of either 1 GM ACh, 4 nM hPK1, or 50 mM KCl (grey arrowheads), 1 GM ACTX-Hvf17 
(black arrowheads) or washout with Krebs solution (white arrowheads). (Ac) Responses of guinea-pig 
ileum longitudinal muscle to 4 nM hPK1 expressed as a percentage of 1 GM ACh before (open column) 
and following incubation with 1 GM ACTX-Hvf17 (grey column). Data represent the mean + SE of 
three individual experiments.  
 
Fig. 5. Pharmacological characterization of ACTX-Hvf17 on hPKR1 receptors expressed in HEK293 
cells. (A) Panel shows dose-dependent increases in [Ca2+]i produced by hPK1 (closed circles) while 
ACTX-Hvf17 (open circles) failed to alter resting calcium flux at concentrations up to 100 nM. (B) 
Antagonist activity assay of ACTX-Hvf17 with hPK1. Increasing concentrations of ACTX-Hvf17 were 
incubated with a fixed concentration of hPK1 (10 nM). Data are means + SE of 4-5 individual 
experiments. 
 
Fig. 6. Modeling of MIT-like ACTX and AVIT family peptides. (A) Schematic view of the NMR 
structure of MIT1 (PDB file 1IMT) showing the location of -strands (cyan arrows) and N-terminal -
helix (green/yellow). The N- and C- termini are labeled and disulfides bridges are shown as red tubes. 
(B) Superimposed 3D structure of MIT1 (green) and putative structure of ACTX-Hvf17 (yellow). Loop 
3 from MIT1 [CGKGTCC] and from ACTX-Hvf17 [CGAGHCC] superimpose with an rmsd over the 
backbone atoms of 0.229. (C-D) Surface charge representations of six modeled MIT-like ACTX and 
AVIT family peptides as labeled compared with the NMR structure of MIT1 below. The colored regions 
on the surfaces represent positively charged (red), negatively charged (blue) and hydrophobic regions 
(white). Panel D shows models rotated 180° around the y-axis with comparison to models in panel C. 
The AVIT family peptides Bv8, rPK1, rPK2 and MIT1 all show a similar surface charge pattern to each 
other whereas the MIT-like ACTX family peptides have very different surface charge patterns to the 
AVIT family peptides as well as themselves. 
 
Fig. 7. The ancestral disulfide-directed -hairpin fold. Schematic representations of (Aa) the ancient 
DDH fold, and (Ab) the more elaborate ICK fold, showing -sheets (arrows), disulfide bonds (horizontal 
lines) and position of loops numbered from the N-terminus (‘N’) to the C-terminus (‘C’). (B) 
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Comparison of MIT-like ACTX with other selected eukaryotic disulfide-directed -hairpin (DDH) 
domains. Domains are grouped into those that occur in isolated (I), duplicated (D) and/or fused (F) form 
as indicated on the left of the panel. The names of AVIT family proteins are highlighted in grey. 
Abbreviations: 	-ACTX-Hv1c, 	-atracotoxin-Hv1c from the venom of the funnel-web spider H. versuta 
[47]; µ-Aga I, µ-agatoxin I from the venom of the unrelated American funnel-web spider Agelenopsis 
aperta [36]; HWTX-II, huwentoxin-II from the venom of the Chinese bird-eating spider Ornithoctonus 
huwena [40]; gurmarin, from the plant Gymnema sylvestre [12]; mBv8, mouse Bv8 [48]; hBv8, human 
Bv8 [48]; PCL, porcine colipase [45]; hDkk-1, human Dickkopf-1 embryonic head inducer (residues 
183-266) [13]; IGFBP-5, insulin-like growth factor binding protein 5 [18]; CBD-CBHI, cellulose 
binding domain of cellobiohydrolase I from the fungus Trichoderma reesei [30]. Remaining 
abbreviations are the same as for Fig. 3. The structures of all these domains have been determined 
except the MIT-like ACTX, PRTx16C0, PRTx16C1, Bv8, Bm8a-f, prokineticins and hDkk-1, whose 
inclusion in this figure is speculative. Note the strong conservation of residues in loop 3 between MIT-
like ACTX family and AVIT family proteins with a consensus sequence of CGXGXCC. ‘N-term’ and 
‘C-term’ indicate the N-terminal and C-terminal DDH folds in proteins where the domain has been 
duplicated.  
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